For patients diagnosed with TTR-related cardiac amyloidosis, experts recommend cardiological evaluations every six months (i.e., cardiology visit, ECG, echocardiogram, and laboratory tests including NT-proBNP and local Troponin T-hs o I-hs), and annually (24-h Holter ECG). This evidence concerns the gene NPPB and cardiac amyloidosis.